Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Immune Responses to COVID-19 Vaccination by an Intervention on the Gut Microbiota: a Randomized Controlled Trial

NCT05195151 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT05195151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05195151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Immune Responses to COVID-19 Vaccination by an Intervention on the Gut Microbiota: a Randomized Controlled Trial
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Completed
Start date
November 10, 2022
Completion date
July 17, 2024
Enrollment
592 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, elderly, vaccine reaction